Sofinnova Investments

VC · Menlo Park (United States)

VC

Seed

Series A

Cloud/SaaS

Climate

Sign up free to access full profile and submit your pitch.

About

Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $3.3B in assets under management and committed capital as of 6/30/2024.

Investment Criteria

Other investors that have backed the same portfolio companies as Sofinnova Investments. Expand any entry to see the shared portfolio companies.

• OrbiMed

  15 shared

  Shared portfolio companies

  • Anthera Pharmaceuticals, Inc.
  • ArriVent BioPharma, Inc.
  • Ascendis Pharma A/S
  • Avenzo Therapeutics, Inc.
  • BioAge Labs, Inc.
  • Edgewise Therapeutics, Inc.
  • ENYO Pharma SA
  • Natera, Inc.
  • NextCure, Inc.
  • ObsEva SA
  • OnCusp Therapeutics, Inc.
  • Prothena Corporation plc
  • Star Therapeutics, Inc.
  • Synlogic, Inc.
  • VISEN Pharmaceuticals (Shanghai) Co., Ltd.
• RA Capital Management

  11 shared

  Shared portfolio companies

  • Aclaris Therapeutics, Inc.
  • Ascendis Pharma A/S
  • BioAge Labs, Inc.
  • Bolt Biotherapeutics, Inc.
  • Coherus Oncology, Inc.
  • Edgewise Therapeutics, Inc.
  • Iterum Therapeutics plc
  • Medeor Therapeutics, Inc.
  • Merus N.V.
  • Natera, Inc.
  • Star Therapeutics, Inc.
• Novo Holdings

  9 shared

  Shared portfolio companies

  • AFYX Therapeutics A/S
  • Edgewise Therapeutics, Inc.
  • Entasis Therapeutics Inc.
  • Expedition Therapeutics Inc.
  • Merus N.V.
  • NorthSea Therapeutics B.V.
  • ObsEva SA
  • OnCusp Therapeutics, Inc.
  • Rainier Therapeutics, Inc.
• Perceptive Advisors

  6 shared

  Shared portfolio companies

  • Axonis Therapeutics, Inc.
  • Edgewise Therapeutics, Inc.
  • Immatics N.V.
  • Marea Therapeutics, Inc.
  • Rapport Therapeutics, Inc.
  • Synlogic, Inc.
• Vivo Capital

  6 shared

  Shared portfolio companies

  • Aclaris Therapeutics, Inc.
  • Ascendis Pharma A/S
  • Bolt Biotherapeutics, Inc.
  • Coherus Oncology, Inc.
  • Medeor Therapeutics, Inc.
  • VISEN Pharmaceuticals (Shanghai) Co., Ltd.
• Foresite Capital

  5 shared

  Shared portfolio companies

  • Avenzo Therapeutics, Inc.
  • Edgewise Therapeutics, Inc.
  • Natera, Inc.
  • Seaport Therapeutics, Inc.
  • Seres Therapeutics, Inc.
• HBM Partners AG

  5 shared

  Shared portfolio companies

  • Antiva Biosciences, Inc.
  • ArriVent BioPharma, Inc.
  • Merus N.V.
  • Natera, Inc.
  • VISEN Pharmaceuticals (Shanghai) Co., Ltd.
• Canaan Partners

  4 shared

  Shared portfolio companies

  • Antiva Biosciences, Inc.
  • Dauntless Pharmaceuticals, Inc.
  • Intrepida Bio, Inc.
  • Iterum Therapeutics plc
• F-Prime Capital

  4 shared

  Shared portfolio companies

  • Aclaris Therapeutics, Inc.
  • Apellis Pharmaceuticals, Inc.
  • ArtBio GmbH
  • OnCusp Therapeutics, Inc.
• Lumira Ventures

  4 shared

  Shared portfolio companies

  • Antiva Biosciences, Inc.
  • Axonis Therapeutics, Inc.
  • First Aid Beverages, Inc.
  • XyloCor Therapeutics, Inc.